Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PRMT5: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
PRMT5 is a gene implicated in neurodegeneration research. Key relationships include: therapeutic target, inhibits, activates. Associated with AD, ALS, ARM. Connected to 76 entities in the SciDEX knowledge graph.
| Gene Symbol | PRMT5 |
| Full Name | Protein Arginine Methyltransferase 5 |
| Aliases | SKB1, JBP1, IBP72, HRMT1L5 |
| Chromosome | 14q11.2 |
| Protein Type | Transferase |
| Function | encodes a type II protein arginine methyltransferase that catalyzes symmetric dimethylation of arginine residues on histones and non-histone substrates. |
| Gene Type | Protein-coding |
| Pathways | Stem Cell |
| UniProt ID | O14744 |
| Ensembl ID | ENSG00000100462 |
| OMIM | 604045 |
| GeneCards | PRMT5 |
| Human Protein Atlas | PRMT5 |
| HGNC | 20601 |
| Entrez Gene | 10419 |
| Associated Diseases | AD, ALS, ARM, BREAST CANCER, Cancer |
| Known Drugs/Compounds | PARP inhibitor |
| Interactions | PRMT1, STAT3, SRC, RHOT1, RB1, CANCER |
| KG Connections | 170 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
PRMT5["<b>PRMT5</b>"]
Cancer{"Cancer"}
PRMT5 -->|"therapeutic target"| Cancer
Cardiovascular{"Cardiovascular"}
PRMT5 -->|"therapeutic target"| Cardiovascular
Ms{"Ms"}
PRMT5 -->|"therapeutic target"| Ms
Tumor{"Tumor"}
PRMT5 -->|"therapeutic target"| Tumor
Als{"Als"}
PRMT5 -->|"therapeutic target"| Als
Carcinoma{"Carcinoma"}
PRMT5 -->|"inhibits"| Carcinoma
PRMT5 -->|"inhibits"| Ms
PRMT5 -->|"inhibits"| Cancer
PRMT5 -->|"inhibits"| Tumor
PRMT5 -->|"regulates"| Cancer
PRMT5 -->|"regulates"| Cardiovascular
ALS{"ALS"}
PRMT5 -->|"inhibits"| ALS
PRMT1["PRMT1"]
PRMT1 -->|"inhibits"| PRMT5
PRMT1 -->|"therapeutic target"| PRMT5
FERROPTOSIS["FERROPTOSIS"]
FERROPTOSIS -->|"inhibits"| PRMT5
GPX4["GPX4"]
GPX4 -->|"inhibits"| PRMT5
CANCER["CANCER"]
CANCER -->|"inhibits"| PRMT5
DNA["DNA"]
DNA -->|"inhibits"| PRMT5
AND["AND"]
AND -->|"inhibits"| PRMT5
DNA -->|"regulates"| PRMT5
AUTOPHAGY["AUTOPHAGY"]
AUTOPHAGY -->|"inhibits"| PRMT5
PRMT1 -->|"regulates"| PRMT5
style PRMT5 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| PARP inhibitor | therapeutic_target | drug | 0.95 |
| Anti-Cancer Drug Resistance | involved_in | phenotype | 0.90 |
| Non-Small Cell Lung Cancer | associated_with | disease | 0.90 |
| anti-cancer drug resistance | drives | phenotype | 0.90 |
| ovarian cancer | therapeutic_target | disease | 0.90 |
| Cancer | targets | disease | 0.90 |
| Ovarian Cancer | therapeutic_target | disease | 0.90 |
| SPLICING | regulates | entity | 0.85 |
| CELL METABOLISM | regulates | entity | 0.85 |
| CANCER DRUG RESISTANCE | contributes_to | entity | 0.85 |
| drug-tolerant cells | promotes | cell_type | 0.85 |
| Cancer | therapeutic_target | disease | 0.85 |
| TRANSCRIPTION | regulates | entity | 0.85 |
| DNA DAMAGE RESPONSE | regulates | entity | 0.85 |
| Breast Cancer | therapeutic_target | disease | 0.85 |
| DNA DAMAGE REPAIR | regulates | entity | 0.80 |
| Non-Small Cell Lung Cancer | biomarker_for | disease | 0.80 |
| IMMUNE CELLS | regulates | entity | 0.80 |
| AUTOPHAGY | regulates | entity | 0.80 |
| CARDIOVASCULAR FUNCTION | regulates | entity | 0.75 |
| CANCER STEM CELL | regulates | entity | 0.75 |
| Als | therapeutic_target | disease | 0.75 |
| NEURONAL FUNCTION | regulates | entity | 0.75 |
| Cancer | associated_with | disease | 0.70 |
| Cardiovascular | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Carcinoma | inhibits | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Cardiovascular | regulates | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| Lung Cancer | therapeutic_target | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Lung Cancer | activates | disease | 0.65 |
| Cancer | interacts_with | disease | 0.65 |
| ALS | interacts_with | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| PRMT1 | inhibits | gene | 0.60 |
| PRMT1 | regulates | gene | 0.60 |
| JAK1 | therapeutic_target | gene | 0.60 |
| MYC | therapeutic_target | gene | 0.60 |
| STAT3 | activates | gene | 0.60 |
| SRC | activates | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PRMT1 | associated_with | gene | 0.80 |
| PRMT1 | interacts_with | gene | 0.80 |
| PRMT1 | inhibits | gene | 0.60 |
| PRMT1 | therapeutic_target | gene | 0.60 |
| GPX4 | inhibits | gene | 0.60 |
| PRMT1 | regulates | gene | 0.60 |
| TLR3 | therapeutic_target | gene | 0.60 |
| RIPK1 | activates | gene | 0.60 |
| RHOT1 | activates | gene | 0.60 |
| FUS | associated_with | gene | 0.60 |
| FUS | inhibits | gene | 0.60 |
| CDK4 | inhibits | gene | 0.60 |
| PRMT1 | targets | gene | 0.60 |
| PRMT4 | targets | gene | 0.60 |
| FERROPTOSIS | inhibits | gene | 0.60 |
| CANCER | inhibits | gene | 0.60 |
| DNA | inhibits | gene | 0.60 |
| DNA | regulates | gene | 0.60 |
| AUTOPHAGY | inhibits | gene | 0.60 |
| KRAS | therapeutic_target | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| RNA | regulates | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| AUTOPHAGY | therapeutic_target | gene | 0.60 |
| HER3 | therapeutic_target | gene | 0.60 |
| EXOSOMES | expressed_in | gene | 0.60 |
| MICRORNAS | expressed_in | gene | 0.60 |
| APOPTOSIS | expressed_in | gene | 0.60 |
| ITGB6 | causes | gene | 0.60 |
| HER3 | causes | gene | 0.60 |
| AND | causes | gene | 0.60 |
| MEK | causes | gene | 0.60 |
| RNA | activates | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| CANCER | interacts_with | gene | 0.60 |
| KRAS | causes | gene | 0.60 |
| RAF | causes | gene | 0.60 |
| DNA | therapeutic_target | gene | 0.60 |
| RNA | therapeutic_target | gene | 0.60 |
| ITGB6 | therapeutic_target | gene | 0.60 |
| RHOT1 | associated_with | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||